CALAFOS

This brand name is authorized in Estonia, Lithuania

Active ingredients

The drug CALAFOS contains one active pharmaceutical ingredient (API):

1 Lanthanum
UNII 490D9F069T - LANTHANUM CARBONATE

Lanthanum is indicated as a phosphate binding agent for use in the control of hyperphosphataemia.

Read about Lanthanum

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
V03AE03 Lanthanum carbonate V Various → V03 All other therapeutic products → V03A All other therapeutic products → V03AE Drugs for treatment of hyperkalemia and hyperphosphatemia
Discover more medicines within V03AE03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1781221, 1781232
Country: LT Valstybinฤ— vaistลณ kontrolฤ—s tarnyba Identifier(s): 1092240, 1092241

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈